{"transactions":[{"id":861775,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62838,"kind":"person","name":"Mowry Anna","position":1,"cik":"0001856938","reported_name":"Mowry Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T22:31:36.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to reporting person's continuous status as a \"Service Provider\" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2026."}],"balance_after":160000,"derivative":{"exercise_price":2.32,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001856938-26-000001","document":"wk-form4_1772663494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000185693826000001/wk-form4_1772663494.xml","form_type":"4"}},{"id":1127774,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62838,"kind":"person","name":"Mowry Anna","position":1,"cik":"0001856938","reported_name":"Mowry Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2025-06-02T21:12:33.000Z","date":"2025-05-29","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.7659,"value":11488.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 15,000 shares purchased in the price range of $0.7662 to $0.7489 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the following shares of Common Stock acquired through the Issuer's 2021 Employee Stock Purchase Plan: (i) 1,250 shares on December 1, 2022; (ii) 1,250 shares on June 1, 2023; (iii) 1,250 shares on December 1, 2023; (iv) 2,500 shares on May 31, 2024; (v) 2,500 shares on November 29, 2024; and (vi) 2,500 shares on May 30, 2025."}],"balance_after":83000,"source":{"system":"sec-edgar","filing":"0001808805-25-000051","document":"wk-form4_1748898746.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000051/wk-form4_1748898746.xml","form_type":"4"}},{"id":1229115,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62838,"kind":"person","name":"Mowry Anna","position":1,"cik":"0001856938","reported_name":"Mowry Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T21:52:41.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, as defined below, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the Reporting Person remains a Service Provider as provided in the Issuer's 2021 Equity Incentive Plan. Vesting Commencement Date shall mean January 1, 2025."}],"balance_after":160000,"derivative":{"exercise_price":1.24,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001808805-25-000025","document":"wk-form4_1741125151.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000025/wk-form4_1741125151.xml","form_type":"4"}},{"id":1596995,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62838,"kind":"person","name":"Mowry Anna","position":1,"cik":"0001856938","reported_name":"Mowry Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-05T21:42:01.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to reporting person's continuous status as a \"Service Provider\" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2024."}],"balance_after":160000,"derivative":{"exercise_price":2.72,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001808805-24-000018","document":"wk-form4_1709674895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880524000018/wk-form4_1709674895.xml","form_type":"4"}},{"id":1983912,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62838,"kind":"person","name":"Mowry Anna","position":1,"cik":"0001856938","reported_name":"Mowry Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-01T22:19:29.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to reporting person's continuous status as a \"Service Provider\" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2023."}],"balance_after":160000,"derivative":{"exercise_price":2,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001808805-23-000031","document":"wf-form4_167770915010174.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880523000031/wf-form4_167770915010174.xml","form_type":"4"}},{"id":2177065,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62838,"kind":"person","name":"Mowry Anna","position":1,"cik":"0001856938","reported_name":"Mowry Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2022-08-22T23:40:43.000Z","date":"2022-08-19","kind":"purchase","acquired":true,"shares":17500,"price":2.2982,"value":40218.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 17,500 shares purchased in the price range of $2.29 to $2.30 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":56750,"source":{"system":"sec-edgar","filing":"0001808805-22-000095","document":"wf-form4_166121152658656.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880522000095/wf-form4_166121152658656.xml","form_type":"4"}},{"id":2220245,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62838,"kind":"person","name":"Mowry Anna","position":1,"cik":"0001856938","reported_name":"Mowry Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2022-06-28T22:17:38.000Z","date":"2022-06-27","kind":"purchase","acquired":true,"shares":5500,"price":2.7499,"value":15124.45,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":39250,"source":{"system":"sec-edgar","filing":"0001808805-22-000075","document":"wf-form4_165645463634483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880522000075/wf-form4_165645463634483.xml","form_type":"4"}},{"id":2372311,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62838,"kind":"person","name":"Mowry Anna","position":1,"cik":"0001856938","reported_name":"Mowry Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-26T01:08:03.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to reporting person's continuous status as a \"Service Provider\" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month).  The Vesting Commencement Date is February 25, 2022."}],"balance_after":280000,"derivative":{"exercise_price":3.78,"expiration_date":"2032-02-25","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001808805-22-000019","document":"wf-form4_164583765686187.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880522000019/wf-form4_164583765686187.xml","form_type":"4"}},{"id":2495491,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62838,"kind":"person","name":"Mowry Anna","position":1,"cik":"0001856938","reported_name":"Mowry Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2021-11-24T22:12:33.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":15000,"price":4.5755,"value":68632.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 15,000 shares purchased in the price range of $4.545 to $4.58 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":32500,"source":{"system":"sec-edgar","filing":"0001808805-21-000023","document":"wf-form4_163779193433755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880521000023/wf-form4_163779193433755.xml","form_type":"4"}},{"id":2602453,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62838,"kind":"person","name":"Mowry Anna","position":1,"cik":"0001856938","reported_name":"Mowry Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2021-08-16T21:12:52.000Z","date":"2021-08-12","kind":"purchase","acquired":true,"shares":17500,"price":7.71,"value":134925.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 17,500 shares purchased in the price range of $7.60 to $7.73 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001808805-21-000012","document":"wf-form4_162914834553171.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880521000012/wf-form4_162914834553171.xml","form_type":"4"}}]}